ArticleBMC musculoskeletal disorders2026
The association between different ejection fractions and all-cause mortality in aged patients with hip fractures: a retrospective cohort study and the development of a predictive model.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHip fractures in the aged are a major public health concern due to high mortality and poor outcomes. While low ejection fraction (EF) is linked to increased mortality in many populations, its impact on aged hip fracture patients is unclear. This study investigates the relationship between EF and all-cause mortality and develops a predictive model based on EF and other clinical factors.
methodsA retrospective cohort study was conducted, including 1,526 aged patients who suffered hip fractures and had EF data recorded. The patients were stratified into three groups based on their EF: normal (EF ≥ 50%), mildly reduced (EF 40%-49%), and severely reduced (EF < 40%). The primary outcome was all-cause mortality, and the secondary outcome was 1-year mortality. Statistical analysis was performed using Kaplan-Meier curves, Cox proportional hazards regression, and multivariate analysis to examine the relationship between EF and mortality. A predictive model for all-cause mortality was developed using multiple clinical factors, and its accuracy was evaluated with the C-index.
resultsA total of 1,526 aged patients with hip fractures were included in the study, with a mean follow-up of 60 months. Multivariate Cox regression analysis identified nine key predictors for 5-year all-cause mortality: age, EF, triglycerides, coronary artery disease, total cholesterol, diabetes, the E/A ratio, stroke volume, and LVED. EF was found to be an independent predictor of mortality (HR = 0.957, 95% CI: 0.93–0.985, p = 0.003). A nomogram incorporating these variables was developed, enabling individualized risk assessment for predicting 1-year, 3-year, and 5-year mortality. Additionally, a web-based dynamic nomogram was created to enhance accessibility, allowing clinicians to input patient-specific data and obtain real-time survival predictions. The nomogram demonstrated excellent predictive performance, with a C-index of 0.827 and AUCs of 0.840, 0.820, and 0.817 for 1-year, 3-year, and 5-year survival, respectively. Calibration curves showed strong agreement between predicted and observed survival probabilities, while decision curve analysis confirmed the model’s clinical utility in guiding personalized risk management.
conclusionThe predictive model developed in this study, based on EF and clinical factors, helps identify aged hip fracture patients at higher risk of mortality, supporting more targeted preoperative and postoperative management. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.